Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 2
1(25.0%)
4Total
N/A(3)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06441539Not ApplicableNot Yet Recruiting

Bingo Drug-eluting Balloon Versus a Drug-eluting Stent for Coronary Bifurcation Lesions

Role: lead

NCT04821726Not ApplicableUnknown

DEB for Symptomatic Intracranial Atherosclerosis Stenosis

Role: lead

NCT04234893Completed

Bingo Drug-Coated Balloon in Real World

Role: lead

NCT02325817Not ApplicableCompleted

Bingo Drug-eluting Balloon in Bifurcation

Role: lead

NCT03201432Phase 2Completed

Drug Eluting Stents Versus Bare Metal Stents for Treatment of Symptomatic Extracranial Vertebral Artery Stenosis

Role: collaborator

All 5 trials loaded